Navigation Links
JDP Therapeutics, Inc. Appoints Christopher M. Cashman to Board of Directors
Date:6/18/2010

JDP Therapeutics, Inc., a specialty pharmaceutical company, announced today the appointment of Christopher M. Cashman to its Board of Directors. Mr. Cashman has an impressive track record in heading start-up pharmaceutical companies and advancing them to exit in addition to having over 30 years of industry experience.

Lansdale, Pennsylvania (PRWEB) June 18, 2010 -- JDP Therapeutics, Inc., a specialty pharmaceutical company, announced today the appointment of Christopher M. Cashman to its Board of Directors. Mr. Cashman has an impressive track record in heading start-up pharmaceutical companies and advancing them to exit in addition to having over 30 years of industry experience.

"Chris has been an invaluable advisor to JDP since its inception working along side founder Jie Du, Ph.D. for the past two years. He has played an integral role in the company’s success to date and we are thrilled that Chris has decided to become a formal member of the team,” said Josh Tarnoff, JDP’s CEO and Executive Board Member. “On a personal note, he is highly respected and well known for his strong integrity and relationships in both the corporate and investment communities.”

Christopher Cashman is co-founder of Protez Pharmaceuticals Inc. and served as Director, President and CEO. Protez was acquired by Novartis in 2008. He was the recipient of the “Entrepreneur of the Year” award at the 2008 MAC Alliance Conference and the “Life Sciences CEO of the Year” by the Eastern Technology Council. He currently also serves on the Board of Directors of Noble Biomaterials, MBF Therapeutics and the Science Center.

“It has been a pleasure working with Jie on the start-up phase of JDP, and now with Josh on board as CEO, JDP is well positioned to advance JDP-205 into the clinic,” said Mr. Cashman.

Company founder Jie Du, Ph.D. added, “The timing for Chris to join our team is especially fitting as we are now poised to move our flagship product into Phase I clinical trial development. We are excited that he will continue to share in our growth and help guide the Board through this very important phase.”

JDP Therapeutics Inc., founded in 2008, is a specialty pharmaceutical company focused on developing small molecule therapeutics to treat life threatening diseases with significant unmet medical needs, primarily for acute care use in the hospital setting.

For further information, please call 215-661-8557 or email info(at)jdptherapeutics(dot)com.

###

Read the full story at http://www.prweb.com/releases/JDP_Therapeutics/Pharmaceuticals/prweb4159384.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Osseon Therapeutics, Inc. Announces it has Received Canadian Medical Device Licenses From Health Canada
2. Cell Therapeutics, Inc. (CTI) Piper Jaffray Presentation to be Webcast
3. EWI Worldwide Appoints Matt Hubbard President, Exhibit Works Division
4. Digital Pathology Services Firm Flagship Biosciences Appoints New CEO
5. Providence Hospital Appoints Four New Members to its Board of Directors
6. iSirona Appoints Chief Quality and Regulatory Officer to Oversee Quality Initiatives
7. Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors
8. Trinity Health Appoints Four to Board of Directors Trinity Health Appoints Four to Board of Directors
9. GeoVax Labs Appoints Two Industry Veterans to Board of Directors
10. Bon Secours Charity Health System Appoints Philip A. Patterson As CEO
11. Touro Appoints Alan Kadish, M.D. President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... Hight-Doland Insurance Agency’s new community involvement ... with Big Brothers Big Sisters of Southwest Louisiana to help provide positive mentoring for ... , Big Brothers Big Sisters of Southwest Louisiana has been helping to guide the ...
(Date:5/4/2016)... Island (PRWEB) , ... May 04, 2016 , ... ... in April 2016. SS&A teamed up with one of the top website design ... information portal contains informative legal articles related to the law firm's main practice ...
(Date:5/4/2016)... ... , ... Recognizing that lifestyle medicine is essential to health and healthcare, ... Katz, MD, MPH, president of the American College of Lifestyle Medicine, as their first ... gratifying,” said Katz. “There is so much opportunity to add years to lives, and ...
(Date:5/4/2016)... CA (PRWEB) , ... May 04, 2016 , ... The ... that ex-supermodel Janice Dickinson needed following breast cancer surgery. In March 2016, the 61-year-old ... a type of breast cancer that occurs in the milk ducts, according to an ...
(Date:5/4/2016)... Prairie du Sac, Wisconsin (PRWEB) , ... ... ... The OMNIFORCE collection delivers next-level compression and support for knees, ankles, and ... a great value. , Innovative 3D flat-bed manufacturing (opposed to ineffective circular ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016 Research and ... Acute Myeloid Leukemia Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... and Competitive Landscape Highlights 2016, provides comprehensive ... Acute Myeloid Leukemia epidemiology, Acute Myeloid Leukemia ...
(Date:5/3/2016)... -- Research and Markets has announced the ... Market Outlook 2020" report to their offering. ... technology has improved significantly in past years due to ... coming years. Many cancer drugs have been developed by ... also expected to be developed with its help. They ...
(Date:5/3/2016)... 3, 2016  While you may be familiar with watching a film or TV show in ... ultra-high-definition or 8MP in the Medical Industry.  Ampronix  is a renowned authorized reseller of the ... Photo - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
Breaking Medicine Technology: